Therapeutics
Developing drugs that target novel biological pathways
Bioprocessing
Products to enhance manufacturing efficiency and economics
Highlights
- Aug 31, 2010: Repligen to Present at the Rodman & Renshaw Annual Global Investment Conference Monday, September 13th, 12:05 p.m. EDT More
- Aug 05, 2010: Repligen Reports First Quarter Fiscal Year 2011 Financial Results Product Sales Increase by 73% More
- Aug 02, 2010: Repligen Receives Additional Research Grants to Support Development of HDAC Inhibitors for Friedreich’s Ataxia and Huntington’s Disease More